Extreme Movers: Gemini 1.5 Pro's picks for 2026-09-08
Gemini 1.5 Pro picked ALAB, LULU, TYRA, PATH, GWRE for a 1-day horizon. Average directional return: -3.23%. Directions called correctly: 20%.
| Experiment | Extreme Movers |
|---|---|
| Model | Gemini 1.5 Pro |
| Prompt version | extreme-movers-v2 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-09-04 |
| Measured to | 2026-09-08 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -3.23% |
| Directions called correctly | 20% |
| Benchmark return | -0.55% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | ALAB | up | -6.94% | -6.94% | 80% | -6.39% | No |
| 2 | LULU | down | +2.56% | -2.56% | 75% | -2.02% | No |
| 3 | TYRA | up | -6.70% | -6.70% | 70% | -6.15% | No |
| 4 | PATH | up | -7.77% | -7.77% | 65% | -7.22% | No |
| 5 | GWRE | down | -7.83% | +7.83% | 60% | +8.37% | Yes |
The model's market view
As we head into the target session following the long Labor Day weekend, broad market sentiment remains cautious but resilient. Technology and earnings-driven narratives will continue to steer the most volatile names. Stocks that missed expectations significantly ahead of the break face structural momentum continuation to the downside, while specific biotech and AI-infrastructure gainers look poised to maintain their speculative momentum as buyers step in on confirmed tailwinds.
Why each pick
ALAB
Astera Labs jumped 9.75% after a robust Q2 2026 earnings beat. The company cited strong demand for its AI fabrics and PCIe connectivity products, cementing its role in the AI data-center buildout. The catalyst is substantive and backed by high forward guidance. Given the secular tailwinds in AI infrastructure, this momentum is highly likely to continue upward as institutional buyers digest the beat.
LULU
Lululemon suffered a massive 17.38% drop following an earnings report that highlighted a drastic slowdown in Mainland China and a severe double-digit revenue decline forecast for Q3. The catalyst is substantive, reflecting deeply deteriorating fundamentals. With shares hovering near the $100 psychological level, panic selling is likely to persist as analysts aggressively cut price targets.
TYRA
Tyra Biosciences rallied 15.25% after scheduling a September 9 conference call to disclose initial Phase 2 SURF302 data for oral dabogratinib. The catalyst is highly speculative but drives intense anticipation. Biotech momentum tends to carry forward into the actual binary data readout, meaning the stock should experience continuation upward as traders position for the news.
PATH
UiPath dropped 16.63% on Friday despite slightly beating Q2 EPS estimates ($0.15 vs $0.15 consensus). The selloff appears overdone relative to the actual financial performance, largely driven by broader software sector rotation rather than an existential business failure. The steep decline sets up favorable risk-reward for a near-term mean-reverting bounce.
GWRE
Guidewire Software plummeted 19.93% after its Q4 earnings report, despite a beat on both top and bottom lines. The steep drop indicates that the stock was priced for absolute perfection, and the market found forward guidance lacking relative to its lofty P/E ratio. We expect this heavy profit-taking and multiple-contraction to continue downward in the coming session.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| GPT-5.6 Sol | NX, GWRE, PATH, FICO, LULU | -4.27% | 0% |
| Muse Spark 1.1 | LULU, PATH, CBRS, SNDK, AEHR | +1.09% | 40% |
| Grok 4.5 | NX, SNDK, GWRE, LULU, PATH | -3.25% | 20% |
| DeepSeek R1 | LULU, FICO, PATH, SNDK, ALAB | +0.39% | 80% |
Written up on ForecastNest Insights: Extreme Movers: Gemini 1.5 Pro's picks for 2026-09-08.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.